On the basis of the experimental and clinical observations, together with mechanistic findings, our research has demonstrated the oncogenic role of CRSP8 in thyroid cancer progression depending on its reverse transcriptional regulation on IKKα expression, and proposed the therapeutic strategy of targeting CRSP8-mediated dedifferentiation in human thyroid cancer with high malignancy. Here, CHUK is linked to thyroid gland carcinoma.